tiprankstipranks
Trending News
More News >
NOVONIX Ltd Sponsored ADR (NVX)
NASDAQ:NVX
Advertisement

NOVONIX Ltd Sponsored ADR (NVX) AI Stock Analysis

Compare
103 Followers

Top Page

NVX

NOVONIX Ltd Sponsored ADR

(NASDAQ:NVX)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
$1.00
▼(-18.03% Downside)
NOVONIX Ltd's stock score is primarily impacted by its poor financial performance, characterized by operational losses and negative cash flows. Technical indicators suggest a bearish trend with limited momentum. The negative P/E ratio and lack of dividend yield further contribute to a low valuation score, reflecting the company's financial instability and unattractiveness as an investment.

NOVONIX Ltd Sponsored ADR (NVX) vs. SPDR S&P 500 ETF (SPY)

NOVONIX Ltd Sponsored ADR Business Overview & Revenue Model

Company DescriptionNovonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. It operates through three segments: Graphite Exploration and Mining, Battery Technology, and Battery Materials. The Graphite Exploration and Mining segment explores for graphite in Australia. The Battery Technology segment develops battery cell testing equipment and batteries, and consulting services. The Battery Materials segment develops and manufactures battery anode materials. The company is also involved in the investment and battery testing activities. Novonix Limited has strategic alliance with Harper International Corporation to develop specialized furnace technology that would enhance Novonix's synthetic graphite manufacturing process; and partnership with Emera Technologies to develop and manufacture energy storage systems for community microgrids. The company was formerly known as Graphitecorp Limited and changed its name to Novonix Limited in July 2017. Novonix Limited was incorporated in 2012 and is headquartered in Brisbane, Australia.
How the Company Makes MoneyNOVONIX generates revenue through multiple key streams, including the sale of high-purity graphite materials and battery testing services. The company leverages its proprietary technologies to produce superior battery materials that meet the increasing demand for electric vehicle batteries and energy storage systems. Additionally, NOVONIX has established strategic partnerships with leading companies in the automotive and energy sectors, which contribute to its revenue growth through collaborative projects and long-term supply agreements. The company's focus on research and development also positions it to capitalize on emerging trends in energy storage, further enhancing its revenue potential.

NOVONIX Ltd Sponsored ADR Financial Statement Overview

Summary
NOVONIX Ltd faces considerable financial challenges, with ongoing operational losses and negative cash flows indicating struggling performance. While the balance sheet shows moderate leverage, the overall financial health requires attention to improve profitability and liquidity. Strategic initiatives to enhance revenue growth and cost efficiency are essential to stabilize the company's financial outlook.
Income Statement
22
Negative
NOVONIX Ltd has faced significant challenges in its profitability, with a negative EBITDA and net income indicating ongoing operational losses. The gross profit margin is positive, but the net profit margin is negative due to high operating expenses. Revenue growth is inconsistent, showing a decline from the previous year. These factors suggest financial instability and a need for improved cost management.
Balance Sheet
35
Negative
The balance sheet shows a moderate debt-to-equity ratio, indicating some leverage but not excessive. The equity ratio is relatively strong, suggesting reliance on equity financing. However, declining stockholders' equity and total assets indicate potential financial strain. The company's financial position is relatively stable but needs improvement in asset and equity management.
Cash Flow
30
Negative
The company has negative operating and free cash flow, indicating challenges in generating cash from operations. The free cash flow growth rate is negative, reflecting financial difficulties. The operating cash flow to net income ratio is unfavorable, suggesting issues in converting income into cash. Overall, cash flow management needs significant improvement.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.85M12.13M6.10M5.23M
Gross Profit4.08M9.32M-20.63M4.38M-3.28M
EBITDA-66.61M-38.86M-33.28M-43.26M-12.04M
Net Income-74.82M-46.25M-38.08M-51.86M-18.08M
Balance Sheet
Total Assets226.10M263.34M189.59M302.98M202.86M
Cash, Cash Equivalents and Short-Term Investments42.56M78.63M73.93M142.74M136.66M
Total Debt70.42M68.22M31.34M42.31M20.01M
Total Liabilities88.51M83.74M38.20M51.85M24.68M
Stockholders Equity137.59M183.94M151.39M251.13M178.18M
Cash Flow
Free Cash Flow-70.32M-55.42M-29.65M-113.02M-25.66M
Operating Cash Flow-40.42M-36.23M-12.89M-29.23M-6.09M
Investing Cash Flow-18.17M-12.04M-16.10M-106.80M-19.68M
Financing Cash Flow25.21M44.16M180.69M103.77M

NOVONIX Ltd Sponsored ADR Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.22
Price Trends
50DMA
1.34
Negative
100DMA
1.26
Negative
200DMA
1.32
Negative
Market Momentum
MACD
-0.02
Positive
RSI
44.50
Neutral
STOCH
34.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NVX, the sentiment is Negative. The current price of 1.22 is below the 20-day moving average (MA) of 1.29, below the 50-day MA of 1.34, and below the 200-day MA of 1.32, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 44.50 is Neutral, neither overbought nor oversold. The STOCH value of 34.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NVX.

NOVONIX Ltd Sponsored ADR Risk Analysis

NOVONIX Ltd Sponsored ADR disclosed 1 risk factors in its most recent earnings report. NOVONIX Ltd Sponsored ADR reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

NOVONIX Ltd Sponsored ADR Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
676.19M-7.18-25.23%14.82%-19.27%
54
Neutral
1.26B-8.53-38.32%20.84%24.84%
51
Neutral
255.13M-0.86-36.15%78.82%-20.81%
50
Neutral
1.98B-12.0260.04%52.49%
43
Neutral
23.28M-0.26-2271.61%-16.98%2.43%
41
Neutral
$198.91M-45.13%-14.27%-28.56%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NVX
NOVONIX Ltd Sponsored ADR
1.22
-0.73
-37.44%
FCEL
Fuelcell Energy
7.90
-4.09
-34.11%
MVST
Microvast Holdings
3.87
3.59
1282.14%
GWH
ESS Tech
1.60
-5.02
-75.83%
ENVX
Enovix
10.09
0.55
5.77%
SLDP
Solid Power
3.73
2.36
172.26%

NOVONIX Ltd Sponsored ADR Corporate Events

NOVONIX Issues New Securities to Strengthen Market Position
Sep 3, 2025

On September 1, 2025, NOVONIX Limited announced the issuance of 250,000 new ordinary fully paid securities on the Australian Securities Exchange (ASX) as a result of the conversion of performance rights. This move is part of the company’s strategy to enhance its capital structure and support its ongoing growth in the battery materials sector. The new securities are intended to rank equally with existing shares, reflecting NOVONIX’s commitment to expanding its market presence and providing value to its stakeholders.

NOVONIX Announces Cessation of Performance Rights
Sep 3, 2025

On September 1, 2025, NOVONIX Limited announced the cessation of 3,236,775 performance rights due to the lapse of conditional rights that were not met. This development affects the company’s issued capital and reflects a strategic adjustment in its equity securities management, potentially impacting investor perceptions and market positioning.

NOVONIX Ltd Issues New Securities Following Convertible Debentures Conversion
Aug 12, 2025

On August 12, 2025, NOVONIX Ltd announced the issuance of 2,800,013 ordinary fully paid securities on the Australian Securities Exchange (ASX). This issuance resulted from the conversion of convertible debentures, reflecting the company’s strategic financial maneuvers to optimize its capital structure. The new securities are intended to be quoted on the ASX, aligning with NOVONIX’s ongoing efforts to enhance its market presence and shareholder value.

NOVONIX and Lithium Energy Withdraw Axon Graphite IPO Amid Market Conditions
Aug 1, 2025

On August 1, 2025, NOVONIX Limited announced that it, along with Lithium Energy Limited, has decided not to proceed with the Initial Public Offering (IPO) of Axon Graphite due to unfavorable market conditions. This decision affects the planned spin-out of their consolidated graphite assets, initially intended to be completed under the Mt Dromedary Share Sale and Purchase Agreement. The company is now reassessing strategies to maximize shareholder value from the Mt Dromedary asset, and NOVONIX’s nominees have resigned from their director positions at Axon Graphite.

NOVONIX Limited Issues New Securities Following Performance Rights Conversion
Jul 30, 2025

On July 29, 2025, NOVONIX Limited announced the issuance of 48,531 ordinary fully paid securities on the Australian Securities Exchange (ASX) as a result of the conversion of performance rights. This move is part of the company’s ongoing efforts to enhance its capital structure by converting existing securities into additional quoted securities, which could potentially improve liquidity and market perception.

NOVONIX Ltd Issues Performance Rights to Boost Employee Engagement
Jul 3, 2025

On July 2, 2025, NOVONIX Ltd announced the issuance of 82,506 performance rights under an employee incentive scheme, which are not intended to be quoted on the ASX. This move is part of the company’s strategy to incentivize its workforce, potentially enhancing employee motivation and aligning their interests with the company’s growth objectives.

NOVONIX Ltd Announces Quotation of New Securities on ASX
Jul 1, 2025

On June 30, 2025, NOVONIX Ltd announced the issuance of 66,896 ordinary fully paid securities on the Australian Securities Exchange (ASX) as a result of options being exercised and convertible securities being converted. This move is part of an employee incentive scheme, with some securities being converted by key management personnel. This development is expected to enhance the company’s operational capabilities and strengthen its market position in the battery materials industry.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2025